Identity
HGNC
LOCATION
20q13.33
LOCUSID
ALIAS
ARM-1,ARM1,GP110,PSMD16
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 11047
MIM: 610650
HGNC: 15759
Ensembl: ENSG00000130706
Variants:
dbSNP: 11047
ClinVar: 11047
TCGA: ENSG00000130706
COSMIC: ADRM1
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000130706 | ENST00000253003 | Q16186 |
| ENSG00000130706 | ENST00000462554 | A0A087WUX6 |
| ENSG00000130706 | ENST00000491935 | Q16186 |
| ENSG00000130706 | ENST00000620230 | A0A087WX59 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38151017 | 2024 | hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-κB p50. | 3 |
| 38890391 | 2024 | The high expression of ADRM1 in hepatocellular carcinoma is closely related to tumor immune infiltration and is regulated by miR-891a-5p. | 0 |
| 38151017 | 2024 | hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-κB p50. | 3 |
| 38890391 | 2024 | The high expression of ADRM1 in hepatocellular carcinoma is closely related to tumor immune infiltration and is regulated by miR-891a-5p. | 0 |
| 37268471 | 2023 | Potential of adhesion-regulating molecule 1 (ADRM1) as a biomarker for patients with renal clear-cell carcinoma or papillary-cell carcinoma. | 0 |
| 37518356 | 2023 | LIM Homeobox 2 Increases Adhesion-Regulating Molecule 1 Transcription to Facilitate the Pathological Progression of Oxidized Low-Density Lipoprotein-Stimulated Atherosclerotic Cell Models. | 0 |
| 37268471 | 2023 | Potential of adhesion-regulating molecule 1 (ADRM1) as a biomarker for patients with renal clear-cell carcinoma or papillary-cell carcinoma. | 0 |
| 37518356 | 2023 | LIM Homeobox 2 Increases Adhesion-Regulating Molecule 1 Transcription to Facilitate the Pathological Progression of Oxidized Low-Density Lipoprotein-Stimulated Atherosclerotic Cell Models. | 0 |
| 32424294 | 2021 | Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13. | 12 |
| 32916039 | 2021 | ADRM1 as a therapeutic target in hepatocellular carcinoma. | 5 |
| 33441535 | 2021 | Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13. | 9 |
| 34916494 | 2021 | Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma. | 11 |
| 32424294 | 2021 | Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13. | 12 |
| 32916039 | 2021 | ADRM1 as a therapeutic target in hepatocellular carcinoma. | 5 |
| 33441535 | 2021 | Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13. | 9 |
Citation
Dessen P
ADRM1 (ADRM1 26S proteasome ubiquitin receptor)
Atlas Genet Cytogenet Oncol Haematol. 2003-06-01
Online version: http://atlasgeneticsoncology.org/gene/591/adrm1
